U.S. flag

An official website of the United States government

NM_002528.7(NTHL1):c.289A>G (p.Lys97Glu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 2, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002320689.2

Allele description [Variation Report for NM_002528.7(NTHL1):c.289A>G (p.Lys97Glu)]

NM_002528.7(NTHL1):c.289A>G (p.Lys97Glu)

Gene:
NTHL1:nth like DNA glycosylase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_002528.7(NTHL1):c.289A>G (p.Lys97Glu)
HGVS:
  • NC_000016.10:g.2046193T>C
  • NG_005895.1:g.1888T>C
  • NG_008412.1:g.6674A>G
  • NM_001318193.2:c.289A>G
  • NM_001318194.2:c.24+87A>G
  • NM_002528.7:c.289A>GMANE SELECT
  • NP_001305122.2:p.Lys97Glu
  • NP_002519.2:p.Lys97Glu
  • LRG_1366t1:c.289A>G
  • LRG_1366:g.6674A>G
  • LRG_1366p1:p.Lys97Glu
  • LRG_487:g.1888T>C
  • NC_000016.9:g.2096194T>C
  • NM_002528.5:c.313A>G
Protein change:
K97E
Molecular consequence:
  • NM_001318194.2:c.24+87A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001318193.2:c.289A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002528.7:c.289A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002608963Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)		Uncertain significance
(Mar 2, 2021) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002608963.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.K105E variant (also known as c.313A>G), located in coding exon 2 of the NTHL1 gene, results from an A to G substitution at nucleotide position 313. The lysine at codon 105 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024